tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Want to see RARE full AI Analyst Report?

Compare Ultragenyx Pharmaceutical (RARE) vs. Competitors

1,215 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$24.81
$2.46B
-2.85
-28.24%
13 Buy
2 Hold
0 Sell
Strong Buy
Travere Therapeutics
$40.77
$3.96B
-18.39
101.37%
12 Buy
1 Hold
0 Sell
Strong Buy
Xenon
$59.70
$5.26B
-12.41
83.94%
19 Buy
0 Hold
0 Sell
Strong Buy
Disc Medicine
$71.77
$2.55B
-9.69
41.98%
10 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$67.24
$2.69B
-108.13
43.63%
8 Buy
0 Hold
0 Sell
Strong Buy
Mineralys Therapeutics, Inc.
$30.58
$2.26B
-14.26
78.26%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
25.00
-11.19
-30.92%
TVTX
Travere Therapeutics
42.59
25.58
150.38%
XENE
Xenon
54.39
23.44
75.74%
IRON
Disc Medicine
66.86
17.18
34.58%
TARS
Tarsus Pharmaceuticals
62.48
17.47
38.81%
MLYS
Mineralys Therapeutics, Inc.
27.38
12.06
78.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts